Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity

NCT03232255 is registered in ClinicalTrials.gov with InQpharm Group as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03232255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity
Lead sponsor
InQpharm Group
Phase
Not applicable
Overall status
Completed
Start date
August 25, 2017
Completion date
December 7, 2017
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.